SMAD3 and type 2 diabetes mellitus: It is also hard to reconcile downregulated PCK2 and SMAD3 transcript levels in tumors from diabetic patients with more vigorous tumor propagation seen in T2DM as PCK2 and SMAD3 have been shown to foster tumor growth and dissemination [36,37].